Arrhythmogenic right ventricular cardiomyopathy

The Lancet

Volumn 373, Issue 9671, 2009, Pages 1289-1300

  Basso, Cristina ^a   Corrado, Domenico ^a   Marcus, Frank I ^b   Nava, Andrea ^a   Thiene, Gaetano ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SOTALOL;

DEFIBRILLATOR; ELECTROCARDIOGRAPHY; GENE MUTATION; GENETIC SCREENING; HEART LEFT VENTRICLE; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH;

EID: 64049101148     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60256-7     Document Type: Review

References (110)

1. Lancisi GM. De Motu Cordis et Aneurysmatibus Opus Posthumum In Duas Partes Divisum. Naples, 1736.
2. Dalla Volta S., Battaglia G., and Zerbini E. "Auricularization" of right ventricular pressure curve. Am Heart J 61 (1961) 25-33
3. Marcus F., Fontaine G., Guirdaudon G., et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 65 (1982) 384-398
4. Fontaine G., Frank R., Guiraudon G., et al. Signification des troubles de conduction intraventriculaire observes dans la dysplasie ventriculaire droite arhythmogène. Arc Mal Coeur 77 (1984) 872-879
5. Thiene G., Nava A., Corrado D., Rossi L., and Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318 (1988) 129-133
6. Nava A., Thiene G., Canciani B., et al. Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol 12 (1989) 1222-1228
7. Nava A., Bauce B., Basso C., et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 36 (2000) 2226-2233
8. Peters S., Trümmel M., and Meyners W. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. Int J Cardiol 97 (2004) 499-501
9. Corrado D., Basso C., Pavei A., Michieli P., Schiavon M., and Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296 (2006) 1593-1601
10. Fontaine G. Arrhythmogenic right ventricular dysplasia. Curr Opin Cardiol 10 (1995) 16-20
11. Gerlis L.M., Schmidt-Ott S.C., Ho S.Y., and Anderson R.H. Dysplastic conditions of the right ventricular myocardium: Uhl's anomaly vs arrhythmogenic right ventricular dysplasia. Br Heart J 69 (1993) 142-150
12. Uhl H.S. A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bull Johns Hopkins Hosp 91 (1952) 197-209
13. Basso C., Thiene G., Corrado D., Angelini A., Nava A., and Valente M. Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy or myocarditis?. Circulation 94 (1996) 983-991
14. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93 (1996) 841-842
15. Basso C., Wichter T., Danieli G.A., et al. Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking. Eur Heart J 25 (2004) 531-534
16. Marcus F., Towbin J.A., Zareba W., et al., for the ARVD/C Investigators. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). A multidisciplinary study: design and protocol. Circulation 107 (2003) 2975-2978
17. Marcus F.I., Nava A., and Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: recent advances (2007), Springer Verlag, Milan
18. Thiene G., and Basso C. Arrhythmogenic right ventricular cardiomyopathy. An update. Cardiovasc Pathol 10 (2001) 109-111
19. Corrado D., Basso C., Thiene G., et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 30 (1997) 1512-1520
20. Basso C., and Thiene G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat?. Cardiovasc Pathol 14 (2005) 37-41
21. Thiene G., Corrado D., Nava A., et al. Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology?. Eur Heart J 12 (1991) 22-25
22. Mallat Z., Tedjui A., Fontaliran F., Frank R., Durigon M., and Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335 (1996) 1190-1196
23. Valente M., Calabrese F., Thiene G., et al. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol 152 (1998) 479-484
24. Bowles N.E., Ni J., Marcus F., and Towbin J.A. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 39 (2002) 892-895
25. Calabrese F., Basso C., Carturan E., Valente M., and Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses?. Cardiovasc Pathol 15 (2006) 11-17
26. Fox P.R., Maron B.J., Basso C., Liu S.K., and Thiene G. Spontaneously occurring arrhythmogenic right ventricular cardiomyopathy in the domestic cat: a new animal model similar to the human disease. Circulation 102 (2000) 1863-1870
27. Basso C., Fox P.R., Meurs K.M., et al. Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation 109 (2004) 1180-1185
28. Protonotarios N., Tsatsopoulou A., Patsourakos P., et al. Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J 56 (1986) 321-326
29. Armstrong D.K., McKenna K.E., Purkis P.E., et al. Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. Hum Mol Genet 8 (1999) 143-148
30. McKoy G., Protonotarios N., Crosby A., et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355 (2000) 2119-2124
31. Rampazzo A., Nava A., Malacrida S., et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 71 (2002) 1200-1206
32. Gerull B., Heuser A., Wichter T., et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 36 (2004) 1162-1164
33. Pilichou K., Nava A., Basso C., et al. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 113 (2006) 1171-1179
34. Syrris P., Ward D., Evans A., et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet 79 (2006) 978-984
35. Beffagna G., De Bortoli M., Nava A., et al. Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro. BMC Med Genet 8 (2007) 65
36. Asimaki A., Syrris P., Wichter T., Mathias P., Saffitz J.E., and McKenna W.J. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Human Genetics 81 (2007) 964-973
37. Norgett E.E., Hatsell S.J., Carvajal-Huerta L., et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet 9 (2000) 2761-2766
38. Sen-Chowdhry S., Syrris P., and McKenna W.J. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 50 (2007) 1813-1821
39. Thiene G., Corrado D., and Basso C. Cardiomyopathies: is it time for a molecular classification?. Eur Heart J 25 (2004) 1772-1775
40. Sen-Chowdhry S., Syrris P., Ward D., Asimaki A., Sevdalis E., and McKenna W.J. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 115 (2007) 1710-1720
41. Syrris P., Ward D., Asimaki A., et al. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation 113 (2006) 356-364
42. van Tintelen J.P., Entius M.M., Bhuiyan Z.A., et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 113 (2006) 1650-1658
43. Antoniades L., Tsatsopoulou A., Anastasakis A., et al. Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis. Eur Heart J 27 (2006) 2208-2216
44. Dalal D., James C., Devanagondi R., et al. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 48 (2006) 1416-1424
45. Corrado D., and Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation 113 (2006) 1634-1637
46. Tiso N., Stephan D.A., Nava A., et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10 (2001) 189-194
47. Beffagna G., Occhi G., Nava A., et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 65 (2005) 366-373
48. Merner N.D., Hodgkinson K.A., Haywood A., et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 82 (2008) 1-13
49. d'Amati G., di Gioia C.R., Giordano C., and Gallo P. Myocyte transdifferentiation: a possible pathogenetic mechanism for arrhythmogenic right ventricular cardiomyopathy. Arch Pathol Lab Med 124 (2000) 287-290
50. Protonotarios N., and Tsatsopoulou A. Naxos disease and Carvajal syndrome: Cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Pathol 13 (2004) 185-194
51. Basso C., Czarnowska E., Della Barbera M., et al. Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur Heart J 27 (2006) 1847-1854
52. Saffitz J.E. Dependence of electrical coupling on mechanical coupling in cardiac myocytes: insights gained from cardiomyopathies caused by defects in cell-cell connections. Ann N Y Acad Sci 1047 (2005) 336-344
53. Kaplan S.R., Gard J.J., Protonotarios N., et al. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 1 (2004) 3-11
54. Kaplan S.R., Gard J.J., Carvajal-Huerta L., Ruiz-Cabezas J.C., Thiene G., and Saffitz J.E. Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol 13 (2004) 26-32
55. Tandri H., Asimaki A., Dalal D., Saffitz J.E., Halushka M.K., and Calkins H. Gap junction remodeling in a case of arrhythmogenic right ventricular dysplasia due to plakophilin-2 mutation. J Cardiovasc Electrophysiol 19 (2008) 1212-1214
56. Fidler L.M., Wilson G.J., Liu F., et al. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations. J Cell Mol Med (2008) 10.1111/j.1582-4934.2008.00438.x published online July 26.
57. Yang Z., Bowles N.E., Scherer S.E., et al. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res 99 (2006) 646-655
58. Garcia-Gras E., Lombardi R., Giocondo M.J., et al. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 116 (2006) 2012-2021
59. Kirchhof P., Fabritz L., Zwiener M., et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114 (2006) 1799-1806
60. Daliento L., Turrini P., Nava A., et al. Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients: similarities and differences. J Am Coll Cardiol 25 (1995) 655-664
61. Bauce B., Frigo G., Marcus F., et al. Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women. Am J Cardiol 102 (2008) 1252-1257
62. Ferreira A.C., Garcia S.A., Pasquale M.A., Canoniero M.J., and Peter A. Arrhythmogenic right ventricular dysplasia in the elderly. Heart Dis 5 (2003) 393-396
63. McKenna W.J., Thiene G., Nava A., et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71 (1994) 215-218
64. Hamid M.S., Norman M., Quraishi A., et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 40 (2002) 1445-1450
65. Nava A., Canciani B., Buja G., et al. Electrovectorcardiographic study of negative T waves on precordial leads in arrhythmogenic right ventricular dysplasia: relationship with right ventricular volumes. J Electrocardiol 21 (1988) 239-245
66. Zareba W., Piotrowicz K., and Turrini P. Electrocardiographic manifestations. In: Marcus F.I., Nava A., and Thiene G. (Eds). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: recent advances (2007), Springer Verlag, Milano 121-128
67. Nasir K., Bomma C., Tandri H., et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation 110 (2004) 1527-1534
68. Cox M.G., Nelen M.R., Wilde A.A., et al. Activation Delay and VT Parameters in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Toward Improvement of Diagnostic ECG Criteria. J Cardiovasc Electrophysiol 19 (2008) 775-781
69. Nava A., Folino A.F., Bauce B., et al. Signal-averaged electrocardiogram in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular arrhythmias. Eur Heart J 21 (2000) 58-65
70. Daliento L., Rizzoli G., Thiene G., et al. Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 66 (1990) 741-745
71. Indik J.H., Wichter T., Gear K., Dallas W.J., and Marcus F.I. Quantitative assessment of angiographic right ventricular wall motion in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). J Cardiovasc Electrophysiol 19 (2008) 39-45
72. Wichter T., Indik J., and Daliento L. Diagnostic role of angiography. In: Marcus F.I., Nava A., and Thiene G. (Eds). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: recent advances (2007), Springer Verlag, Milan 147-158
73. Yoerger D.M., Marcus F., Sherrill D., et al. Multidisciplinary study of right ventricular dysplasia investigators. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. J Am Coll Cardiol 45 (2005) 860-865
74. Yoerger-Sanborn D., Picard M.H., and Bauce B. Echocardiography. In: Marcus F.I., Nava A., and Thiene G. (Eds). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: recent advances (2007), Springer Verlag, Milan 129-134
75. Bluemke D.A., Krupinski E.A., Ovitt T., et al. MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology 99 (2003) 153-162
76. Tandri H., Calkins H., and Bluemke D.A. MR and CT imaging. In: Marcus F.I., Nava A., and Thiene G. (Eds). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: recent advances (2007), Springer Verlag, Milano 135-146
77. Tandri H., Macedo R., Calkins H., et al. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. Am Heart J 155 (2008) 147-153
78. Tandri H., Saranathan M., Rodriguez E.R., et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 45 (2005) 98-103
79. Sen-Chowdhry S., Prasad S.K., Syrris P., et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol 48 (2006) 2132-2140
80. Bomma C., Dalal D., Tandri H., et al. Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol 100 (2007) 99-105
81. Corrado D., Basso C., Leoni L., et al. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/displasia. Circulation 111 (2005) 3042-3050
82. Corrado D., Basso C., Leoni L., et al. Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol 51 (2008) 731-739
83. Angelini A., Basso C., Nava A., and Thiene G. Endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy. Am Heart J 132 (1996) 203-206
84. Ott P., Marcus F.I., and Sobonya R.E. Cardiac sarcoidosis masquerading as right ventricular dysplasia. Pacing Clin Electrophysiology 26 (2003) 1498-1503
85. Chimenti C., Pieroni M., Maseri A., and Frustaci A. Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol 43 (2004) 2305-2313
86. Avella A., d'Amati G., Pappalardo A., et al. Diagnostic value of endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Electrophysiol 19 (2008) 1127-1134
87. Basso C., Ronco F., Marcus F., et al. Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J 29 (2008) 2760-2771
88. Corrado D., Basso C., and Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 83 (2000) 588-595
89. Henriksen E., Kangro T., Jonason T., et al. An echocardiographic study of right ventricular adaptation to physical exercise in elite male orienteers. Clin Physiol 18 (1998) 498-503
90. Ector J., Ganame J., van der Merwe N., et al. Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. Eur Heart J 28 (2007) 345-353
91. Biffi A., Pelliccia A., Verdile L., et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 40 (2002) 446-452
92. Sen-Chowdhry S., Lowe M.D., Sporton S.C., and McKenna W.J. Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am J Med 117 (2004) 685-695
93. Pelliccia A., Di Paolo F.M., Quattrini F.M., et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 358 (2008) 152-161
94. Bauce B., Frigo G., Benini G., et al. Differences and similarities between arrhythmogenic right ventricular cardiomyopathy and athletes's heart adaptations. Br J Sports Med (2008) 10.1136/bjsm.2007.042853 published online July 4.
95. Basso C., Corrado D., and Thiene G. Arrhythmogenic right ventricular cardiomyopathy in athletes: diagnosis, management, and recommendations for sport activity. Cardiol Clin 25 (2007) 415-422
96. Thiene G., Nava A., Angelini A., Daliento L., Scognamiglio R., and Corrado D. Anatomoclinical aspects of arrhythmogenic right ventricular cardiomyopathy. In: Baroldi G., Camerini F., and Goodwin J.F. (Eds). Advances in cardiomyopathies (1990), Springer Verlag, Milano 397-408
97. Thiene G., Angelini A., Basso C., Calabrese F., and Valente M. Novel heart diseases requiring transplantation. Adv Clin Path 2 (1998) 65-73
98. Wlodarska E.K., Wozniak O., Konka M., Rydlewska-Sadowska W., Biederman A., and Hoffman P. Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Europace 8 (2006) 596-600
99. Bauce B., Basso C., Rampazzo A., et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 26 (2005) 1666-1675
100. Norman M., Simpson M., Mogensen J., et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation 112 (2005) 636-642
101. Fontaine G., Fontaliran F., Hébert J.L., et al. Arrhythmogenic right ventricular dysplasia. Annu Rev Med 50 (1999) 17-35
102. Hulot J.S., Jouven X., Empana J.P., Frank R., and Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 110 (2004) 1879-1884
103. Turrini P., Corrado D., Basso C., Nava A., Bauce B., and Thiene G. Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation 103 (2001) 3075-3080
104. Corrado D., Leoni L., Link M.S., et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108 (2003) 3084-3091
105. Corrado D., Basso C., Rizzoli G., Schiavon M., and Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol 42 (2003) 1959-1963
106. Bauce B., Daliento L., Frigo G., Russo G., and Nava A. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy. Eur J Obstet Gynecol 127 (2006) 186-189
107. Wichter T., Borggrefe M., Haverkamp W., Chen X., and Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 86 (1992) 29-37
108. Wichter T., Paul M., Eckardt L., et al. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?. Herz 30 (2005) 91-101
109. Wichter T., Paul M., Wollman C., et al. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 109 (2004) 1503-1508
110. Dalal D., Jain R., Tandri H., et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 50 (2007) 432-440